🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Trump Stings Stocks And Market Cycles Point To More Pain

Published 06/30/2018, 11:26 AM
Updated 07/09/2023, 06:31 AM
US500
-
JPM
-
AMZN
-
CVS
-
HOG
-
WBA
-
CL
-
BRKa
-
US90274J5618=UBSS
-
XOP
-
OIH
-

Summary:

• The S&P 500 was down 1.3% last week, due in part to due to President Trump’s attempt to place restrictions on foreign investment.
Crude oil rose another 8% last week, gushing a total of 13% in the last week and half.
• Amazon (NASDAQ:AMZN) took its next step in its plan to enter the health sector with the acquisition with online pharmacy, PillPack.
• Our projection this week in stocks is for the S&P 500 to decline to the 2670 level over the coming two weeks.
S&P 500 (SPX) Daily Chart

Trump dabbles with foreign investment policy
Last weekend, news surfaced that the Trump administration was planning to propose new rules for foreign investment in US technology firms. However, on Monday, the administration gave mixed signals, with Treasury Secretary Steve Mnuchin saying it would apply to all firms, and trade policy advisor Peter Navarro saying it would apply only to Chinese firms.

Also factoring in, Harley-Davidson Inc (NYSE:HOG) announced its plans to shift some of its production from the US to Europe in an effort to circumvent the European Union’s plans to impose tariffs on American motorcycles. Their decision was based in part on the high cost of the steel tariffs and the proposed European tariffs. As well, Harley’s European sales are growing by 8%, while its US growth is waning. By the end of the day, the stock market fell 1.4%.

By Wednesday, instead of developing new investment restrictions, Trump had endorsed efforts to pass bipartisan legislation that would strengthen the Committee on Foreign Investment in the United States (CFIUS). While some called this a softening of his stance, this approach has the benefit of not explicitly targeting China, while likely having the same impact.

Crude continues to spurt

Crude oil rose 8% last week, after having already popped 5% the previous week, once OPEC had engineered a convoluted supply increase. As for this week, oil increased 3% on both Tuesday and Wednesday after the Trump administration signaled that it would continue to implement the Iranian economic sanctions. It rose again on Thursday and Friday.

After dropping on Monday, the SPDR S&P Oil & Gas Exploration & Production (NYSE:XOP) and the VanEck Vectors Oil Services (NYSE:OIH) ETFs each increased over 3% for the remainder of the week. In total, oil had gushed 13% in the last week and half.

Amazon takes next step to enter health sector

On Thursday, Amazon.com Inc (NASDAQ:AMZN) rose over 2% after announcing that it had agreed to pay $1 billion for the privately-held online pharmacy, PillPack. Traditional pharmacies such as Walgreens Boots Alliance Inc (NASDAQ:WBA), CVS Health (NYSE:CVS) and Rite Aid Corporation (NYSE:RAD) each fell over 10% on the news. The acquisition is unlikely to have a near-term effect on these pharmacies.

The significance is the “Amazon effect” which occurs after Amazon decides to enter and disrupt a new market. In the case of healthcare, this should be taken together with the announcement a few months ago that Amazon, Berkshire Hathaway (NYSE:BRKa) and JP Morgan Chase (NYSE:JPM) would form a partnership. While few details have been released, it is expected that the partnership would provide healthcare to each company’s employees.

The relevant issues are not only whether Amazon will be successful in its latest attempt at disruption, but how long it will take and how its rivals will respond.

Our expectation for this week

Last week was action packed, and we expect more to come. However, US trading will likely slow down this week, with a half day on Tuesday and a full holiday on Wednesday in celebration of Independence Day.

In any case, each week we like to clarify our expectations for the stock market and the other markets we watch. Our approach uses technical analysis focused on market cycles to project price action. Given the shortened schedule, we will look ahead for the coming two weeks.

According to the askSlim Stock Index Report, our analysis of the S&P 500 is for stocks to continue their move lower. Using the dotted blue cycle brackets on the chart above, we believe that the SPX is in the declining phase of its current market cycle. It will likely continue this move, with 2670 as a conservative projection. A break below the 2677 level would be a break below where SPX began the cycle. This would be a bearish signal, depending of course on the extent of the breakdown. Check out the askSlim Market Week for a more detailed analysis of the S&P 500 (SPX) chart.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.